Rajendra, A., Maze, D., Bankar, A., Chan, S., Davidson, M., Gupta, V., Minden, M., Perusini, M., Richard-Carpentier, G., Schimmer, A., Schuh, A., Smith, E., Yee, K. W., Sibai, H. (2025). FLT3 inhibition with midostaurin offsets poor prognosis in NPM1/FLT3/DNMT3a triple-mutated AML. Blood. https://doi.org/10.1182/blood-2025-1672